title: Melan-A/MART-1-specific CD8 T cells: from thymus to tumor.
authors.affiliation: Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, University Hospital (CHUV), 1011 Lausanne, Switzerland.
authors.forename: Mikaël J
authors.initials: MJ
authors.lastname: Pittet
authors.forename: Alfred
authors.initials: A
authors.lastname: Zippelius
authors.forename: Danila
authors.initials: D
authors.lastname: Valmori
authors.forename: Daniel E
authors.initials: DE
authors.lastname: Speiser
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Cerottini
authors.forename: Pedro
authors.initials: P
authors.lastname: Romero
mesh_terms: D000951:Antigens, Neoplasm; D001324:Autoantigens / Q000276:immunology*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D019496:Cancer Vaccines / Q000276:immunology; D006412:Hematopoietic Stem Cells / Q000276:immunology; D006801:Humans; D058965:MART-1 Antigen; D008545:Melanoma / Q000276:immunology* / Q000517:prevention & control; D009363:Neoplasm Proteins / Q000276:immunology*; D013950:Thymus Gland / Q000276:immunology*
chemical_list: D000951:Antigens, Neoplasm; D001324:Autoantigens; D019496:Cancer Vaccines; D058965:MART-1 Antigen; C548667:MLANA protein, human; D009363:Neoplasm Proteins